A. Schubert-Tennigkeit

Does Smoking Decrease the Susceptibility for SARS-CoV-2?

A. Schubert-Tennigkeit, 2020 .

Efficacy and Safety of Bimagrumab in Sporadic Inclusion Body Myositis

D. Papanicolaou, V. S. Williams, L. Tankó, 2020, Neurology.

Long-Term Maintenance Bronchodilation With Indacaterol/Glycopyrrolate Versus Indacaterol in Moderate-to-Severe COPD Patients: The FLIGHT 3 Study.

G. Ferguson, F. Patalano, D. Banerji, 2016, Chronic obstructive pulmonary diseases.

Pooled safety analysis of the fixed-dose combination of indacaterol and glycopyrronium (QVA149), its monocomponents, and tiotropium versus placebo in COPD patients.

J. Wedzicha, R. Dahl, R. Buhl, 2014, Respiratory medicine.

Bimagrumab to improve recovery after hip fracture in older adults: a multicentre, double-blind, randomised, parallel-group, placebo-controlled, phase 2a/b trial.

D. Papanicolaou, L. Tankó, L. Hofbauer, 2021, The Lancet. Healthy longevity.

Efficacy and Safety of Bimagrumab in Sporadic Inclusion Body Myositis: Long-Term Extension of RESILIENT.

D. Papanicolaou, V. S. Williams, L. Tankó, 2021, Neurology.